Your browser doesn't support javascript.
loading
Clinical analysis of retropharyngeal lymph node metastasis in patients with hypopharyngeal squamous cell carcinoma / 中华肿瘤杂志
Chinese Journal of Oncology ; (12): 955-961, 2023.
Article 在 Zh | WPRIM | ID: wpr-1045827
Responsible library: WPRO
ABSTRACT

Objective:

To analyze the incidence and the related risk factors of retropharyngeal lymph node metastasis in patients with hypopharyngeal squamous cell carcinoma, evaluate the accuracy of preoperative enhanced CT in judging retropharyngeal lymph node metastasis, and investigate the impact of retropharyngeal lymph node metastasis on the prognosis.

Methods:

Retrospective analyses were made on 398 patients with hypopharyngeal squamous cell carcinoma who underwent surgery as the primary therapy and accepted retropharyngeal lymph node exploration and clearance during surgery in Shandong Provincial ENT Hospital from January 2014 to December 2019. Multivariate logistic regression analysis was used to clarify the related risk factors of retropharyngeal lymph node metastasis. Multivariate Cox regression analysis was used to investigate the impact of retropharyngeal lymph node metastasis on prognosis. The retropharyngeal lymph nodes of 218 cases with available preoperative enhanced CT images were evaluated by two experienced radiologists and compared with postoperative pathological results.

Results:

Retropharyngeal lymph node metastasis were confirmed in 54 of 398 (13.6%) cases according to postoperative pathology. The sensitivity and specificity of preoperative enhanced CT in the diagnosis of retropharyngeal lymph node metastasis were 34.6% and 91.1%, respectively, and the overall accuracy was 84.4%. Multivariate logistic regression analysis showed that the site of the primary lesion and pathological N stage were independent risk factors for retropharyngeal lymph node metastasis in hypopharyngeal squamous cell carcinoma. Patients with primary lesion located in the posterior wall of hypopharynx (OR=4.83, 95% CI 1.27-18.40), N2 stage (OR=6.30, 95% CI 2.25-17.67), and N3 stage (OR=26.89, 95% CI 5.76-125.58) were prone to retropharyngeal lymph node metastasis. The 5-year overall survival rate of the 398 patients was 50.4%, and the 5-year disease-free survival rate was 48.3%. Multivariate Cox regression analysis showed that T stage, N stage, retropharyngeal lymph node metastasis, and radiotherapy were independent influencing factors for overall survival (T stage HR=1.28, 95% CI 1.06-1.54; N stage HR=1.26, 95% CI 1.14-1.40; retropharyngeal lymph node metastasis HR=2.13, 95% CI 1.47-3.08; radiotherapy HR=0.54, 95% CI 0.38-0.76) and disease-free survival of patients with hypopharyngeal squamous cell carcinoma (T stage HR=1.26, 95% CI 1.06-1.51; N stage HR=1.25, 95% CI 1.13-1.37; retropharyngeal lymph node metastasis HR=2.24, 95% CI 1.56-3.21; radiotherapy HR=0.55, 95% CI 0.40-0.77).

Conclusions:

Metastasis of retropharyngeal lymph nodes in hypopharyngeal squamous cell carcinoma is not rare. Enhanced CT is of low accuracy and limited value in diagnosing retropharyngeal lymph node metastasis. Primary lesions located in the posterior wall of the hypopharyngx, N2 stage, and N3 stage are independent high-risk factors for retropharyngeal lymph node metastasis. The prognosis of hypopharyngeal cancer patients with retropharyngeal lymph node metastasis is worse, and active surgical exploration and clearance can effectively reduce the mortality caused by retropharyngeal lymph node metastasis.
Subject(s)
Key words
全文: 1 索引: WPRIM 主要主题: Prognosis / Carcinoma, Squamous Cell / Hypopharyngeal Neoplasms / Retrospective Studies / Squamous Cell Carcinoma of Head and Neck / Head and Neck Neoplasms / Lymph Nodes / Lymphatic Metastasis / Neoplasm Staging 限制: Humans 语言: Zh 期刊: Chinese Journal of Oncology 年: 2023 类型: Article
全文: 1 索引: WPRIM 主要主题: Prognosis / Carcinoma, Squamous Cell / Hypopharyngeal Neoplasms / Retrospective Studies / Squamous Cell Carcinoma of Head and Neck / Head and Neck Neoplasms / Lymph Nodes / Lymphatic Metastasis / Neoplasm Staging 限制: Humans 语言: Zh 期刊: Chinese Journal of Oncology 年: 2023 类型: Article